hyaluronic acid + ginkgo biloba

**Hyaluronic acid + ginkgo biloba** is a preservative-free ophthalmic combination product marketed as **TRIUM** for ocular surface disorders, particularly dry eye disease, allergic conjunctivitis, and post-traumatic ocular surface alterations. The formulation contains **0.15% sodium hyaluronate** and **0.05% ginkgo biloba extract** and is developed/manufactured by **Fidia Farmaceutici** and distributed by **SOOFT Italy**. Its therapeutic effect is primarily local and non-target-based: hyaluronic acid acts as a viscoelastic tear substitute and lubricant that hydrates, protects, and stabilizes the ocular surface and tear film, while ginkgo biloba extract is used for antioxidant and protective support against ocular surface irritation and inflammation. It is best characterized as a **topical ophthalmic medical device combination product** rather than a conventional small-molecule or biologic drug. Clinical evidence cited for the combination includes use after cataract surgery, where adjunctive HA-GB eye drops improved tear break-up time, symptoms, conjunctival hyperemia, and tolerability versus standard postoperative care alone.

Brand names

TRIUMTRIUM FreeTRIUM UD

Other names

hyaluronic acid + ginkgo bilobasodium hyaluronate + ginkgo biloba extractHA-GB